This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Index funds distribute capital gains at occasional dates; knowing when helps you coordinate withdrawals and tax planning effectively.
25,550 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A quiet day on the stock market today turned volatile for Boston Scientific after it reaffirmed full-year growth guid...
A hot new Snowflake product could change how companies store and analyze data. This guide breaks down what it means f...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...
U.S. Q1 GDP was revised higher to a 2.1% annualized pace, topping prior estimates. The gain sparks relief in markets ...
Micron insiders are unloading stock at a pace not seen since 2010, even as MU rockets on AI memory demand. This piece...
Two software giants sit at the crossroads of business efficiency and security. This guide breaks down Salesforce and ...
A fast-growing company with a software-led model and global expansion is catching investor attention. This growth sto...
Ambiq Micro shares jumped as investors priced in stronger demand for ultra-low-power edge AI technology. This article...
McDonald’s unveils a $3 meal, intensifying the battle for America’s cheapest menu. Investors weigh margin risk as val...
SolarEdge leads a solar-stock surge, jumping about 14% as Canadian Solar adds strength. Investors cite AI infrastruct...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...